- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/02 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
Patent holdings for IPC class C07D 209/02
Total number of patents in this class: 221
10-year publication summary
5
|
8
|
9
|
12
|
10
|
16
|
27
|
16
|
14
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Amgen Inc. | 3899 |
8 |
AnaSpec Incorporated | 27 |
8 |
Cytokinetics, Inc. | 268 |
8 |
Georgia State University Research Foundation, Inc. | 343 |
6 |
Medshine Discovery Inc. | 607 |
6 |
Beth Israel Deaconess Medical Center, Inc. | 859 |
5 |
Genentech, Inc. | 3869 |
3 |
Merck Sharp & Dohme Corp. | 2219 |
3 |
Boehringer Ingelheim International GmbH | 4754 |
3 |
The Board of Trustees of the Leland Stanford Junior University | 6246 |
3 |
Amira Pharmaceuticals, Inc. | 70 |
3 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 670 |
3 |
Eli Lilly and Company | 3720 |
3 |
Illumina Cambridge Limited | 678 |
3 |
Kymera Therapeutics, Inc. | 201 |
3 |
Caamtech, Inc. | 106 |
3 |
Sony Corporation | 31541 |
2 |
The General Hospital Corporation | 4650 |
2 |
The Trustees of Columbia University in the City of New York | 3524 |
2 |
Purdue Research Foundation | 3477 |
2 |
Other owners | 142 |